Search results for Regn

Latest updates for Regn

Fresh curated links around REGN are collected here so marketers can spot useful updates and turn timely ideas into posts faster.

Post angles to try

Share the most useful takeaway for your audience.

Turn one article into a quick practical checklist.

Ask your audience how this shift affects their work.

Turn angles into scheduled posts

Fresh articles and ideas

Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.

seekingalpha.com /1 month ago

Regeneron Pharmaceuticals, Inc. (REGN) Discusses C5 Complement Development Program Focusing on Cemdisiran and Pozelimab...

Read source

seekingalpha.com /2 weeks ago

Regenxbio: 'Hold' On RGX-121 CRL MPS II And RGX-202 DMD Results

Read source

fiercebiotech.com /2 weeks ago

Regenxbio reaps pivotal win for Duchenne muscular dystrophy gene therapy

Regenxbio’s gene therapy for Duchenne muscular dystrophy has smashed the primary endpoint of its pivotal trial, securing a win for a biotech that has struggled in recent months und...

Read source

seekingalpha.com /1 week ago

Apogee Therapeutics: Targeting Atopic Dermatitis

Read source

genengnews.com /1 week ago

StockWatch: Regenxbio Tumbles Despite Positive Pivotal Data for DMD Gene Therapy Candidate

Investors and analysts concluded Regenxbio's positive data was not encouraging enough to pose a competitive threat to the developer of the first marketed DMD gene therapy, Sarepta...

Read source

pharmexec.com /1 week ago

<![CDATA[Regeneron Enters $2.3 Billion Collaboration with Parabilis Medicines to Discover & Develop Multiple Ther...

Read source

aha.org /1 month ago

White House announces MFN agreement with drug manufacturer Regeneron

The administration Apri 23 reached a most-favored-nation drug pricing agreement with Regeneron, the maker of the popular cholesterol medicine Praluent. This is the 17th such agreem...

Read source

pharmexec.com /1 month ago

<![CDATA[Regeneron Enters $2.1 Billion Radiopharma Collaboration with Telix Pharmaceuticals ]]>

Read source

pharmexec.com /1 month ago

<![CDATA[Regeneron Agrees to Lower Drug Costs for U.S. Patients and Provide Otarmeni for Free]]>

Read source

biopharmadive.com /2 weeks ago

With new data, Regenxbio to seek FDA approval of Duchenne gene therapy

Though two serious side effects muddied the results, CEO Curran Simpson expressed optimism about a clearance and claimed FDA leadership will have a “mandate on rare disease flexibi...

Read source

ryortho.com /3 weeks ago

Regeneration, ReNu®, and the Race Against Knee OA

If your clinic schedule is anything like most, knee osteoarthritis (OA) isn’t just a diagnosis — it’s practically a recurring character.

Read source

Turn fresh research into a full content calendar

Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.